G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022
Share
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 7.65 million compared to TWD 3.63 million a year ago. Net loss was TWD 2.91 million compared to TWD 4.64 million a year ago. Basic loss per share from continuing operations was TWD 0.05 compared to TWD 0.08 a year ago.
For the six months, sales was TWD 14.9 million compared to TWD 11.85 million a year ago. Net loss was TWD 7.92 million compared to TWD 7.97 million a year ago. Basic loss per share from continuing operations was TWD 0.14 compared to TWD 0.14 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.